Clinical Assessment of Late Health Outcomes in Survivors of Wilms Tumor
Topic overview
Long-term study of 280 Wilms tumor survivors reveals threefold higher burden of chronic health conditions compared to controls, with significant endocrine, cardiovascular, and pulmonary complications. Survivors also demonstrate neurocognitive and physical function impairments decades after treatment with nephrectomy, chemotherapy, and radiation.
Key takeaways
- Wilms tumor survivors have 3x more chronic health conditions than controls by age 40, averaging 7.5 grade 2-4 conditions vs 2.3 in controls
- Most prevalent late effects: endocrine (54%), cardiovascular (26%), pulmonary (18%), neurologic (9%), secondary cancers (8%), kidney (7%)
- Survivors show significant neurocognitive impairments and physical function deficits compared to age-matched controls
- Treatment exposures: 100% nephrectomy, 99% vincristine, 67% doxorubicin, 59% abdominal radiation, 25% chest radiation
- Individualized surveillance and counseling recommended for long-term health maintenance in this survivor population
Comments